Developing the role of the drug and therapeutics committees: Perceptions of chairs

International Journal of Health Care Quality Assurance

Volumn 20, Issue 2, 2007, Pages 161-178

  Björkman, Ingeborg K ^a,b   Schmidt, Ingrid K ^c   Holmström, Inger ^a   Bernsten, Cecilia B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Apoteket AB   (Sweden)

^c NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

Author keywords

Health services; Patients; Public interest; Sweden

Indexed keywords

ADMINISTRATIVE PERSONNEL; ARTICLE; HUMAN; MANAGEMENT; PHARMACY AND THERAPEUTICS COMMITTEE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; ROLE PLAYING; SWEDEN;

ADMINISTRATIVE PERSONNEL; HUMANS; PHARMACY AND THERAPEUTICS COMMITTEE; POLICY MAKING; QUESTIONNAIRES; ROLE; SWEDEN;

EID: 33847345061     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860710731843     Document Type: Article

References (49)

1. Alexandersson, M. (1994), "Metod och medvetande (Method and awareness)", dissertation, Acta Universitatis Gothoburgensis, Gothenburg.
2. Beard, K. (1992), "Adverse reactions as a cause of hospital admission in the aged", Drugs and Aging, Vol. 2 No. 4, pp. 356-67.
3. Bjorkman, I.K., Bernsten, C.B., Schmidt, I.K. and Holmstrom, I. (2005), "The role of drug and therapeutics committees", International Journal of Health Care Quality Assurance, Vol. 18 Nos 4-5, pp. 235-48.
4. Church, J., Saunders, D., Wanke, M., Pong, R., Spooner, C. and Dorgan, M. (2002), "Citizen participation in health decision-making: past experience and future prospects", Journal of Public Health Policy, Vol. 23 No. 1, pp. 12-32.
5. Collier, J. and Iheanacho, I. (2002), "The pharmaceutical industry as an informant", Lancet, Vol. 360 No. 9343, pp. 1405-9.
6. Coulter, A. and Magee, H.E. (Eds) (2003), The European Patient of the Future, McGraw-Hill Education, Open University Press, Buckingham.
7. Dahlgren, L., Emmelin, M. and Winkvist, A. (2004), Qualitative Metholodogy for International Public Health, Epidemiology and Public Health Sciences, Umeå University, Umeå.
8. Dall'Alba, G. (1998), "Medical practice as characterised by beginning medical students", Advances in Health Sciences Education, Vol. 3, pp. 101-8.
9. de Leeuw, E.D. and van der Zouwen, J. (1991), "Data quality in telephone and face to face surveys: a comparative meta-analysis", in Biemer, P.P., Groves, R.M., Lyberg, L.E., Mathiowetz, N.A. and Sudman, S. (Eds), Measurement Errors in Surveys, Wiley, New York, NY, pp. 283-99.
10. Ebbesen, J., Buajordet, I., Erikssen, J., Brors, O., Hilberg, T., Svaar, H. and Sandvik, L. (2001), "Drug-related deaths in a department of internal medicine", Archives of Internal Medicine, Vol. 161 No. 19, pp. 2317-23.
11. Freemantle, N. and Hill, S. (2002), "Medicalisation, limits to medicine, or never enough money to go around?", British Medical Journal, Vol. 324 No. 7342, pp. 864-5.
12. Gandhi, T.K., Weingart, S.N., Borus, J., Seger, A.C., Peterson, J., Burdick, E., Seger, D.L., Shu, K., Federico, F., Leape, L.L. and Bates, D.W. (2003), "Adverse drug events in ambulatory care", New England Journal of Medicine, Vol. 348 No. 16, pp. 1556-64.
13. Holmstrom, I., Halford, C. and Rosenqvist, U. (2003), "Swedish health care professionals' diverse understandings of diabetes care", Patient Education and Counseling, Vol. 51 No. 1, pp. 53-8.
14. Juntti-Patinen, L. and Neuvonen, P.J. (2002), "Drug-related deaths in a university central hospital", European Journal of Clinical Pharmacology, Vol. 58 No. 7, pp. 479-82.
15. Larsson, J. (2004), "Anaesthetists and professional excellence. Specialist and trainee anaethetists' understanding of their work as a basis for professional development, a qualitative study", dissertation, Uppsala University, Uppsala.
16. Larsson, J., Holmstrom, I. and Rosenqvist, U. (2003), "Professional artist, good Samaritan, servant and co-ordinator: four ways of understanding the anaesthetist's work", Acta Anaesthesiologica Scandinavica, Vol. 47 No. 7, pp. 787-93.
17. Lazarou, J., Pomeranz, B.H. and Corey, P.N. (1998), "Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies", Journal of the American Medical Association, Vol. 279 No. 15, pp. 1200-5.
18. Lincoln, Y. and Guba, E. (1985), Naturalistic Inquiry, Sage, Beverly Hills, CA.
19. Lipsky, M. (1980), Street-level Bureaucracy: Dilemmas of the Individual in Public Service, Russel Sage Foundation, New York, NY.
20. Little, P., Everitt, H., Williamson, I., Warner, G., Moore, M., Gould, C., Ferrier, K. and Payne, S. (2001), "Preferences of patients for patient centred approach to consultation in primary care: observational study", British Medical Journal, Vol. 322, pp. 468-72.
21. Litva, A., Coast, J., Donovan, J., Eyles, J., Shepherd, M., Tacchi, J., Abelson, J. and Morgan, K. (2002), "'The public is too subjective': public involvement at different levels of health-care decision making", Social Science and Medicine, Vol. 54 No. 12, pp. 1825-37.
22. Malterud, K. (1998), Kvalitativa metoder i medicinsk forskning (Qualitative Methods in Medical Research), Studentlitteratur, Lund.
23. Mannesse, C.K., Derkx, F.H., de Ridder, M.A., Man in 't Veld, A.J. and van der Cammen, T.J. (2000), "Contribution of adverse drug reactions to hospital admission of older patients", Age and Ageing, Vol. 29 No. 1, pp. 35-9.
24. Marton, F. and Booth, S. (2000), Om lärande, Studentlitteratur, Lund (also available in English: Learning and Awareness (1997), L. Erlbaum Associates, Inc., Mahwah, NJ).
25. Mazmanian, D.A. and Sabatier, P.A. (1983), Implementation and Public Policy, Scott, Foresman and Company, Glenview, IL.
26. Mjorndal, T., Boman, M.D., Hagg, S., Backstrom, M., Wiholm, B.E., Wahlin, A. and Dahlqvist, R. (2002), "Adverse drug reactions as a cause for admissions to a department of internal medicine", Pharmacoepidemiol. Drug Saf., Vol. 11 No. 1, pp. 65-72.
27. Morgan, S.G., Bassett, K.L., Wright, J.M., Evans, R.G., Barer, M.L., Caetano, P.A. and Black, C.D. (2005), "'Breakthrough' drugs and growth in expenditure on prescription drugs in Canada", British Medical Journal, Vol. 331 No. 7520, pp. 815-16.
28. Moynihan, R., Heath, I. and Henry, D. (2002), "Selling sickness: the pharmaceutical industry and disease mongering", British Medical Journal, Vol. 324 No. 7342, pp. 886-91.
29. Ong, L.M., de Haes, J.C., Hoos, A.M. and Lammes, F.B. (1995), "Doctor-patient communication: a review of the literature", Social Science and Medicine, Vol. 40 No. 7, pp. 903-18.
30. Pickard, S. and Smith, K. (2001), "A 'third way' for lay involvement: what evidence so far?", Health Expectations, Vol. 4 No. 3, pp. 170-9.
31. Pickard, S., Marshall, M., Rogers, A., Sheaff, R., Sibbald, B., Campbell, S., Halliwell, S. and Roland, M. (2002), "User involvement in clinical governance", Health Expectations, Vol. 5 No. 3, pp. 187-98.
32. Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A.K., Walley, T.J., Farrar, K., Park, B.K. and Breckenridge, A.M. (2004), "Adverse drug reactions as cause of admission to hospital: prospective analysis of 18, 820 patients", British Medical Journal, Vol. 329 No. 7456, pp. 15-19.
33. Pouyanne, P., Haramburu, F., Imbs, J.L. and Begaud, B. (2000), "Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres", British Medical Journal, Vol. 320 No. 7241, p. 1036.
34. Pressman, J.L. and Wildawsky, A. (1973), Implementation. How Great Expectations in Washington Are Dashed in Oakland: Or Why it's Amazing that Federal Programs Work at All, University of California Press, Berkeley, CA.
35. Rosén, A. and Beermann, B. (1999), "Rating innovative therapeutic benefits of medicines licensed in Sweden 1987-1997", Int. J. Pharm. Med., Vol. 13, pp. 123-6.
36. Spångberg Winblad, U. (2003), "Från beslut till verklighet. Läkarnas roll vid implementeringen av valfrihetsreformer i hälso-och sjukvården" ("From decision to practice. The role of the physician in implementing patient choice in Swedish health care"), dissertation, Uppsala University, Uppsala.
37. Sparkes, A.C. (2001), "Myth 94: qualitative health researchers will agree about validity", Qualitative Health Research, Vol. 11 No. 4, pp. 538-52.
38. Stalsby Lundborg, C., Wahlstrom, R. and Dall'Alba, G. (1999), "Ways of experiencing asthma management. Variations among general practitioners in Sweden", Scandinavian Journal of Primary Health Care, Vol. 17, pp. 226-31.
39. Stewart, M.A. (1995), "Effective physician-patient communication and health outcomes: a review", Can. Med. Ass. J., Vol. 152 No. 9, pp. 1423-33.
40. Swedish Commission (1997), "Patienten har rätt. Betänkande från Kommittén om hälso- och sjukvårdens finansiering och organisation, HSU 2000 (The patient is right. Report from the Committee of health care financing and organisation, HSU 2000)", SOU 1997:154, available at: www.regeringen.se/sb/d/108/a/25107 (accessed 22 December 2005).
41. Swedish Commission (1999), God vård på lika villkor? - om statens styrning av hälso- och sjukvården. Betänkande från Kommittén om hälso- och sjukvårdens finansiering och organisation, HSU 2000 (Good care on equal conditions? - about the government direction of the health care. Report from the Committee of health care financing and organisation, HSU 2000)", SOU 1999:66, available at: www.regeringen.se/content/1/c6/02/25/75/5be1e7e6.pdf (accessed 22 December 2005).
42. Swedish National Board of Health and Welfare (2004), "En uppföljning av läkemedelskommittéernas arbete - Hur påverkas läkemedelsanvändningen? (The Drug and Therapeutic Committees - A follow up. How do they influence drug use?)" (in Swedish)", National Board of Health and Welfare, Stockholm, available at: www.sos.se/FULLTEXT/103/2004-103-1/2004-103-1.pdf (accessed 22 December 2005).
43. Swedish National Board of Health and Welfare (2005), "Lä kemedelsförsäljning i Sverige - analys och prognos, november 2005 (Drug expenditure in Sweden - analysis and prognosis, November 2005)", Socialstyrelsen (The Board of Health and Welfare), Stockholm, available at: www.socialstyrelsen.se/NR/rdonlyres/FF101298-DEE2-40ED-992C-63BFE826484A/4373/ 20051037.pdf (accessed 22 December 2005).
44. Traulsen, J.M. and Almarsdottir, A.B. (2005), "Pharmaceutical policy and the lay public*", Pharmacy World & Science, Vol. 27 No. 4, pp. 273-7.
45. Villanueva, P., Peiro, S., Librero, J. and Pereiro, I. (2003), "Accuracy of pharmaceutical advertisements in medical journals", Lancet, Vol. 361 No. 9351, pp. 27-32.
46. Wazana, A. (2000), "Physicians and the pharmaceutical industry: is a gift ever just a gift?", Journal of the American Medical Association, Vol. 283 No. 3, pp. 373-80.
47. Winter, S. (1990), "Integrating implementation research", in Palumbo, D.J. and Calista, O.J. (Eds), Implementation and Policy Process, Greenwood Press, New York, NY, pp. 19-38.
48. Wiseman, V., Mooney, G., Berry, G. and Tang, K.C. (2003), "Involving the general public in priority setting: experiences from Australia", Social Science and Medicine, Vol. 56 No. 5, pp. 1001-12.
49. Yee, J.L., Hasson, N.K. and Schreiber, D.H. (2005), "Drug-related emergency department visits in an elderly veteran population", Annals of Pharmacotherapy, Vol. 39 No. 12, pp. 1990-4.